Overexpression of AMPKα1 ameliorates fatty liver in hyperlipidemic diabetic rats

Korean Journal of Physiology and Pharmacology

Volumn 13, Issue 6, 2009, Pages 449-454

  Seo, Eunhui ^a   Park, Eun Jin ^a   Joe, Yeonsoo ^a   Kang, Soojeong ^a   Kim, Mi Sun ^a   Hong, Sook Hee ^a   Park, Mi Kyoung ^a   Kim, Duk Kyu ^a   Koh, Hyongjong ^a   Lee, Hye Jeong ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Adenovirus; AMP activated protein kinase (AMPK); AMPK 1 catalytic subunit; Fatty liver; OLETF; Type 2 diabetes

Indexed keywords

5' AMP ACTIVATED PROTEIN KINASE ALPHA1; ACETYL COENZYME A CARBOXYLASE; ADENOVIRUS VECTOR; PROTEIN KINASE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY LIVER; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HYPERGLYCEMIA; HYPERLIPIDEMIA; LIPID METABOLISM; LIPOGENESIS; LIVER LEVEL; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 75749083676     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2009.13.6.449     Document Type: Article

References (26)

1. Asilmaz E, Cohen P, Miyazaki M, Dobrzyn P, Ueki K, Fayzik-hodjaeva G, Soukas AA, Kahn CR Ntambi JM, Socci ND, Friedman JM. Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest 113: 414-424, 2004.
2. Cohen P, Ntambi JM, Friedman JM. Stearoyl-CoA desaturase-1 and the metabolic syndrome. Curr Drug Targets Immune Endocr Metabol Disord 3: 271-280, 2003.
3. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-Aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 229: 558-565, 1995.
4. Crawford RM, Treharne KJ, Arnaud-Dabemat S, Daniel JY, Foretz M, Viollet B, Mehta A. Understanding the molecular basis of the interaction between NDPK-A and AMPK alpha 1. Mol Cell Biol 26: 5921-5931, 2006.
5. Dobrzyn A, Ntambi JM. The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med 14: 77-81, 2004.
6. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54: 1331-1339, 2005.
7. Fryer LG, Parbu-Patel A, Carling D. Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4-imidazolecarboxamide riboside. FEBS Lett 531: 189-192, 2002.
8. Hardie DG. AMP-activated protein kinase: a master switch in glucose and lipid metabolism. Rev Endocr Metab Disord 5: 119-125, 2004.
9. Hardie DG, Carling D. The AMP-activated protein kinase. Fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273, 1997.
10. Hardie DG, Carling D, Carlson M. The amp-activated/snf1 protein kinase subfamily: Metabolic Sensors of the Eukaryotic Cell? Annu Rev Biochem 67: 821-855, 1998.
11. Hardie DG, Pan DA. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase. Biochem Soc Trans 30: 1064-1070, 2002.
12. Hardie DG, Scott JW, Pan DA, Hudson ER M.anagement of cellular energy by the AMP-activated protein kinase system. FEBS Lett 546: 113-120, 2003.
13. Kawano K, Hirashima T, Mori S, Kurosumi M, Saitoh Y, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima fatty (OLETF) strain. Diabetes 41: 1422-1428, 1992.
14. Minokoshi Y, Kim YB, Peroni OD, Fryer LG, Muller C, Carling D, Kahn BB. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343, 2002.
15. Muoio DM, Seefeld K, Witters LA, Coleman RA. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that glycerol-3-phosphate acyltransferase is a novel target. Biochem J 338: 783-791, 1999.
16. Musi N, Hayashi T, Fujii N, Hirshman MF, Witters LA, Goodyear LJ. AMP-activated protein kinase activity and glucose uptake in rat skeletal muscle. Am J Physiol Endocrinol Metab 280: E677-E684, 2001.
17. Reiter AK, Bolster DR, Crazier SJ, Kimball SR Jefferson LS. Repression of protein synthesis and mTOR signaling in rat liver mediated by the AMPK activator aminoimidazole carboxamide ribonucleoside. Am J Physiol Endocrinol Metab 288: E980-E988, 2005.
18. Pencek RR, Shearer J, Camacho RC, James FD, Lacy DB, Fueger PT, Donahue EP, Snead W, Wasserman DH. 5-Aminoimidazole-4-carboxamide-1-β- d-ribofuranoside causes acute hepatic insulin resistance in vivo. Diabetes 54: 355-360, 2005.
19. Rutter GA, Xavier GDS, Leclerc I. Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375: 1-16, 2003.
20. Saha AK, Avilucea PR, Ye JM, Assifi MM, Kraegen EW, Ruderman NB. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 314: 580-585, 2004.
21. Thong FS, Graham TE. The putative roles of adenosine in insulin-and exercise-mediated regulation of glucose transport and glycogen metabolism in skeletal muscle. Can J Appl Physiol 27: 152-178, 2002.
22. Winder WW, Hardie D. AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am J Physiol 277: E1-10, 1999.
23. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB, Clayton RD, Conley LM, Yoon S, Zhou B. Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase. A J Appl Physiol 82: 219-225, 1997.
24. Wojtaszewski JF, Jorgensen SB, Hellsten Y, Hardie DG, Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle. Diabetes 51: 284-292, 2002.
25. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel F, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R Kahn BB, Kadowaki T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002.
26. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174, 2001.